PLoS ONE (Jan 2022)

Correction: Infliximab for pediatric patients with Crohn’s disease: A Phase 3, open-label, uncontrolled, multicenter trial in Japan

  • Hitoshi Tajiri,
  • Satoshi Motoya,
  • Fukunori Kinjo,
  • Atsuo Maemoto,
  • Takayuki Matsumoto,
  • Noriko Sato,
  • Hiroshi Yamada,
  • Mieko Nagano,
  • Yutaka Susuta,
  • Kunihiko Ozaki,
  • Kazuoki Kondo,
  • Toshifumi Hibi

Journal volume & issue
Vol. 17, no. 4

Abstract

Read online

No abstracts available.